SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-00-030698
Filing Date
2000-06-30
Accepted
2000-06-30 00:00:00
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.PBIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 2 sc13ga.txt SC 13G/A 19022
2 EXHIBIT A AGREEMENT REGARDING JOINT FILING ex-1.txt EX-1 2116
  Complete submission text file 0000912057-00-030698.txt   23796
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 8586587600
NEUROCRINE BIOSCIENCES INC (Subject) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46089 | Film No.: 666695
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice